FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Market Withdrawal of Immune Globulin Intravenous (Human), GAMMAGARD S/D, 10 gm

horizontal rule

DATE RECALL INITIATED:

June 24, 2004

LOT NUMBER / EXPIRATION DATE:

LE08D030AA     3/30/2006

MANUFACTURER:

Baxter SA
Lessines, Belgium

REASON:

There has been an increased frequency of adverse event reports of allergic reactions associated with this lot. Although none of these reactions have been life threatening, two reported reactions involved the airway, and all reactions required medical intervention. The firm requests the use of this lot be immediately discontinued, and the affected product be returned to the manufacturer.

horizontal rule

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

 

 
horizontal rule